Chemo Fog (Record no. 110608)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03549nam a22004575i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 978-1-4419-6306-2 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20140220084509.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 110110s2010 xxu| s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781441963062 |
| -- | 978-1-4419-6306-2 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/978-1-4419-6306-2 |
| Source of number or code | doi |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | R-RZ |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MBGR |
| Source | bicssc |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED000000 |
| Source | bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 610 |
| Edition number | 23 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Raffa, Robert B. |
| Relator term | editor. |
| 245 10 - TITLE STATEMENT | |
| Title | Chemo Fog |
| Medium | [electronic resource] : |
| Remainder of title | Cancer Chemotherapy-Related Cognitive Impairment / |
| Statement of responsibility, etc | edited by Robert B. Raffa, Ronald J. Tallarida. |
| 264 #1 - | |
| -- | New York, NY : |
| -- | Springer New York, |
| -- | 2010. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | XX, 212p. 27 illus. |
| Other physical details | online resource. |
| 336 ## - | |
| -- | text |
| -- | txt |
| -- | rdacontent |
| 337 ## - | |
| -- | computer |
| -- | c |
| -- | rdamedia |
| 338 ## - | |
| -- | online resource |
| -- | cr |
| -- | rdacarrier |
| 347 ## - | |
| -- | text file |
| -- | |
| -- | rda |
| 490 1# - SERIES STATEMENT | |
| Series statement | Advances in Experimental Medicine and Biology, |
| International Standard Serial Number | 0065-2598 ; |
| Volume number/sequential designation | 678 |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Short Introduction and History -- Patient’s Perspective -- Oncology Nurse’s Perspective -- Oncology Pharmacist’s Perspective -- The Impact of Chemo Brain on the Patient with a High-Grade Glioma -- Neurocognitive Effects of Childhood Cancer Treatment -- The Economic Burden -- Designing Conceptual Model-Based Research in Chemotherapy-Related Changes in Cognitive Function -- Neuropsychologic Testing for Chemotherapy-Related Cognitive Impairment -- Imaging as a Means of Studying Chemotherapy-Related Cognitive Impairment -- Chemotherapy Associated Central Nervous System Damage -- Is Systemic Anti-Cancer Therapy Neurotoxic? Does Chemo Brain Exist? And Should We Rename It? -- Evaluation of Multiple Neurotoxic Outcomes in Cancer Chemotherapy -- Chemotherapy-Related Visual System Toxicity -- The Possible Role of Cytokines in Chemotherapy-Induced Cognitive Deficits -- Pharmacokinetics of Anti-Cancer Drugs Used in Breast Cancer Chemotherapy -- Combination Analysis -- Animal Models -- Chemo Brain (Chemo Fog) as a Potential Side Effect of Doxorubicin Administration: Role of Cytokine-Induced, Oxidative/Nitrosative Stress in Cognitive Dysfunction -- Effects of 5-FU -- Future Directions. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | The editors of this book are professors who are engaged in research on areas that compromise the total healing of body and mind in this patient population. One particular component of the need for survivor care is the memory problems and cognitive deficits experienced by some. The condition has been given a name––actually many names, such as chemo fog, chemo brain, and others. These names reflect the belief that the cause of the problem is the chemotherapy that they received as part of their treatment. In some cases the chemo fog/’chemo brain’ is transient while in others it is of longer duration. Little is known about this problem and that fact peaked our interest and motivated this book. Therefore this book is devoted to one aspect of survivor care: chemo fog/’chemo brain’. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medicine. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Oncology. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Biomedicine. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Biomedicine general. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Cancer Research. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tallarida, Ronald J. |
| Relator term | editor. |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY | |
| Title | Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Display text | Printed edition: |
| International Standard Book Number | 9781441963055 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Advances in Experimental Medicine and Biology, |
| -- | 0065-2598 ; |
| Volume number/sequential designation | 678 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | http://dx.doi.org/10.1007/978-1-4419-6306-2 |
| 912 ## - | |
| -- | ZDB-2-SBL |
No items available.